Sera Prognostics, Inc. (SERA)
2.16
-0.14
(-6.09%)
USD |
NASDAQ |
Apr 07, 16:00
2.195
+0.04
(+1.62%)
After-Hours: 20:00
Sera Prognostics Total Assets (Quarterly) : 102.55M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | 27.12M |
| Celldex Therapeutics, Inc. | 582.98M |
| Plus Therapeutics, Inc. | 16.32M |
| Atossa Therapeutics, Inc. | 47.61M |
| Abeona Therapeutics, Inc. | 221.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.14M |
| Shareholders Equity (Quarterly) | 75.41M |
| Debt to Equity Ratio | 0.031 |
| Current Ratio | 1.686 |
| Net Debt Paydown Yield | -0.22% |